QW
Qian Wang
Investor at Pivotal bioVenture Partners
San Francisco, California
Overview
Qian Wang is a Biotech Investor based in San Francisco, California, with a background in healthcare equity analysis at BlackRock and Bank of America Merrill Lynch. Currently serving as a Biotech investor at Pivotal bioVenture Partners, Qian has a strong track record in investing in early-stage biotech companies and providing strategic guidance.
Highlights of Qian's career include roles as a Healthcare Equity Analyst at BlackRock and Vice President Equity Research at Bank of America Merrill Lynch, showcasing expertise in analyzing and investing in the pharmaceutical and biotech sectors.
Work Experience
Biotech investor
2022 - Current
Private and public biotech investor
Board Observer
2022
HotSpot Therapeutics is a developer of a therapy platform designed to discover medicines and provide proper treatment.
Raised $210,000,000.00 from Pavilion Capital, Revelation Partners, SR One, LSP BioVentures, Monashee Investment Management, B Capital, Atlas Venture, Sofinnova Partners, CaaS Capital Management and Pivotal bioVenture Partners.
Healthcare Equity Analyst
2019 - 2022
Healthcare investor focused on biotech and pharma across multiple therapeutics areas including oncology, gene therapy/editing, immunology and rare diseases
information contained on the LifePath Paycheck website is intended
Vice President Equity Research/ Covering Analyst
2015 - 2019
Covered large-cap and SMid cap biotechnology names; facilitate many biotech IPOs
Associate
2015 - 2015
Board Member
2010 - 2014